Stereotaxis (STXS) Depreciation & Amortization (CF) (2010 - 2026)
Stereotaxis (STXS) reported Depreciation & Amortization (CF) of $159000.0 for Q1 2026, up 1.92% year-over-year from $156000.0 in Q1 2025, and up 0.63% quarter-over-quarter from $158000.0 in Q4 2025.
Stereotaxis (STXS) Depreciation & Amortization (CF) (2010 - 2026) Analysis & Trends
Stereotaxis (STXS) has 17 years of Depreciation & Amortization (CF) data on file, last reported at $159000.0 in Q1 2026.
- Depreciation & Amortization (CF) for Q1 2026 came in at $159000.0, up 1.92% year-over-year; the trailing twelve-month figure through Mar 2026 was $629000.0 (up 4.31% YoY), and the FY2025 annual result was $626000.0, up 6.64% from the prior year.
- Depreciation & Amortization (CF) rose to $159000.0 in Q1 2026 per STXS's latest filing, from $158000.0 in the prior quarter.
- Over five years, Depreciation & Amortization (CF) peaked at $160000.0 in Q1 2023 and troughed at $94000.0 in Q2 2022.
- A 5-year average of $140941.2 and a median of $150000.0 in 2023 frame the typical range for Depreciation & Amortization (CF).
- On a YoY basis, Depreciation & Amortization (CF) climbed as much as 403.85% in 2022 and fell as far as 94.12% in 2022.
- A 5-year view of Depreciation & Amortization (CF) shows it stood at $131000.0 in 2022, then advanced by 5.34% to $138000.0 in 2023, then rose by 15.22% to $159000.0 in 2024, then decreased by 0.63% to $158000.0 in 2025, then advanced by 0.63% to $159000.0 in 2026.
- Business Quant data shows STXS's Depreciation & Amortization (CF) at $159000.0 in Q1 2026, $158000.0 in Q4 2025, and $156000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 178.90 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 563.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 254.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 58.98 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 44.60 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 135.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 95.40 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 56.55 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 237.00 Mn |
| 10 | Stereotaxis | 180.48 Mn | 165.86 Mn | 3.79 Mn | 159,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 159,000.00 |
| Mar 31, 2026 | 159,000.00 |
| Dec 31, 2025 | 158,000.00 |
| Dec 31, 2025 | 158,000.00 |
| Sep 30, 2025 | 156,000.00 |
| Sep 30, 2025 | 156,000.00 |
| Jun 30, 2025 | 156,000.00 |
| Jun 30, 2025 | 156,000.00 |
| Mar 31, 2025 | 156,000.00 |
| Mar 31, 2025 | 156,000.00 |
| Dec 31, 2024 | 159,000.00 |
| Dec 31, 2024 | 159,000.00 |
| Sep 30, 2024 | 152,000.00 |
| Sep 30, 2024 | 152,000.00 |
| Jun 30, 2024 | 136,000.00 |
| Jun 30, 2024 | 136,000.00 |
| Mar 31, 2024 | 140,000.00 |
| Mar 31, 2024 | 140,000.00 |
| Dec 31, 2023 | 138,000.00 |
| Dec 31, 2023 | 138,000.00 |